Your search returned 3 results.

Results
	1.	Albiglutide, a weekly GLP-1 receptor agonist, improves glycemic parameters in Japanese patients with type 2 diabetes over 1 year when added to single oral antidiabetic drugs. [electronic resource] by Okuda, Inaha Wilson, Timothy H Yue, Lin Nakajima, Hiromu Carr, Molly C Tsuboi, Maho Nino, Antonio Seino, Yutaka Producer: 20170928 In: Current medical research and opinion vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. [electronic resource] by Nino, Antonio Okuda, Inaha Wilson, Timothy H Yue, Lynn Nakajima, Hiromu Tsuboi, Maho Carr, Molly C Seino, Yutaka Publication details: Journal of diabetes investigation Sep 2017 In: Journal of diabetes investigation Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus. [electronic resource] by Seino, Yutaka Inagaki, Nobuya Miyahara, Hajime Okuda, Inaha Bush, Mark Ye, June Holland, M Claire Johnson, Susan Lewis, Eric Nakajima, Hiromu Producer: 20150602 In: Current medical research and opinion vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)